Cannabics Pharmaceuticals Inc. Share Price Other OTC
Equities
CNBX
US13764M1009
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | 4L 3.42Cr | Capitalization | 4L 2.94Cr |
---|---|---|---|---|---|
Net income 2022 | -30L -25Cr | Net income 2023 | -30L -25Cr | EV / Sales 2022 | - |
Net Debt 2022 | 16.41L 14Cr | Net Debt 2023 | 12.14L 10Cr | EV / Sales 2023 | 3.82 x |
P/E ratio 2022 |
-1.12
x | P/E ratio 2023 |
-0.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15/04/15 |
Gabriel Yariv
CHM | Chairman | 47 | 07/19/07 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 05/16/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eyal Barad
FOU | Founder | 58 | 15/04/15 |
Gabriel Yariv
CHM | Chairman | 47 | 07/19/07 |
1st Jan change | Capi. | |
---|---|---|
+16.44% | 12TCr | |
+18.94% | 11TCr | |
+18.52% | 2.62TCr | |
-25.37% | 1.9TCr | |
-19.98% | 1.57TCr | |
-20.20% | 1.52TCr | |
-47.37% | 1.47TCr | |
+59.91% | 1.46TCr | |
+4.35% | 1.38TCr |